<i>CD79B</i> <scp>Y196</scp> mutation is a potent predictive marker for favorable response to <scp>R‐MPV</scp> in primary central nervous system lymphoma-Reference-Cited by-同舟云学术

CD79B Y196 mutation is a potent predictive marker for favorable response to R‐MPV in primary central nervous system lymphoma

Published:2022-12-07 Issue:6 Volume:12 Page:7116-7126
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Yamaguchi Junya¹,Ohka Fumiharu¹^ORCID,Lushun Chalise²,Motomura Kazuya¹,Aoki Kosuke¹,Takeuchi Kazuhito¹,Nagata Yuichi¹,Ito Satoshi³,Mizutani Nobuhiko³,Ohno Masasuke⁴⁵^ORCID,Suzaki Noriyuki⁵,Takasu Syuntaro⁶,Seki Yukio⁶,Kano Takahisa⁷,Wakabayashi Kenichi⁸,Oyama Hirofumi⁸,Kurahashi Shingo⁹,Tanahashi Kuniaki¹,Hirano Masaki¹,Shimizu Hiroyuki¹,Kitano Yotaro¹,Maeda Sachi¹,Yamazaki Shintaro¹,Wakabayashi Toshihiko¹¹⁰,Kondo Yutaka¹¹,Natsume Atsushi¹,Saito Ryuta¹

Affiliation:

1. Department of Neurosurgery Nagoya University Graduate School of Medicine Nagoya Japan

2. Department of Neurosurgery Nagoya Central Hospital Nagoya Japan

3. Department of Neurosurgery Konan Kosei Hospital Konan Japan

4. Department of Neurosurgery Aichi Cancer Center Hospital Nagoya Japan

5. Department of Neurosurgery Nagoya Medical Center Nagoya Japan

6. Department of Neurosurgery Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Nagoya Japan

7. Department of Neurosurgery Anjo Kosei Hospital Anjo Japan

8. Department of Neurosurgery Toyohashi Municipal Hospital Toyohashi Japan

9. Department of Hematology and Oncology Toyohashi Municipal Hospital Toyohashi Japan

10. Department of Neurosurgery Nagoya Kyoritsu Hospital Nagoya Japan

11. Division of Cancer Biology Nagoya University Graduate School of Medicine Nagoya Japan